A fluorescent protein-tagged peptide toxin as a tool for KV1.3 visualisation (#215)
Voltage-gated potassium channels play a key role in T-cell activation [1]. Homotetrameric KV1.3 channels are specifically upregulated in effector memory T-cells (TEM), which have been implicated in autoimmune diseases including rheumatoid arthritis, psoriasis, multiple sclerosis and type I diabetes [2]. It is therefore of interest to be able to identify such KV1.3-expressing cells. However, fluorescent conjugates of antibodies or small molecules may not be able to distinguish homotetrameric KV1.3 channels from heterotetrameric KV1.3/KV1.x channels. In contrast, a number of animal-derived peptide toxins that bind the extracellular vestibule of the channel exhibit selectivity for KV1.3 homotetramers [3]. One example is HsTX1[R14A], an analogue of a 34-residue peptide toxin from the scorpion Heterometrus spinifer that binds KV1.3 with an IC50 of 45 pM and displays a 2000-fold selectivity for KV1.3 over KV1.1 [4].
Labelling of peptide toxins with small-molecule fluorophores is potentially costly and synthetically challenging as residues commonly used for fluorophore attachment may also be critical for toxin folding and function [5]. Earlier work has demonstrated the feasibility of tagging peptide toxins with fluorescent proteins by recombinant expression [6]. A possible limitation is that many peptide toxins require oxidising conditions to form native disulfide bonds. To address this issue, we have developed a construct comprising HsTX1[R14A] and an N-terminal GFP variant [7] containing Cys-to-Ser mutations compatible with an oxidising expression environment. The fusion protein was successfully produced by periplasmic expression in E. coli, purified by nickel affinity and size-exclusion chromatography, and assessed by UV-Vis spectroscopy and 1H 1D NMR. We are currently optimising the length and composition of the linker between GFP and HsTX1[R14A], with variants to be evaluated for KV1.3 inhibition using electrophysiology assays. Once validated, GFP-HsTX1[R14A] would be an accessible and cost-effective tool for studying KV1.3-expressing cells in applications such as confocal imaging and fluorescence-activated cell sorting.
- E.Y. Chiang, et al., Nature Commun. 8, 14644 (2017)
- J. Lam and H. Wulff, Drug Develop. Res. 72, 573-584 (2011)
- R.S. Norton and K.G. Chandy, Neuropharmacology. 127, 124-138 (2017)
- M.H. Rashid, et al., Sci Rep-UK. 4, 4509 (2014)
- A.I. Kuzmenkov and A.A. Vassilevski, Neurosci Lett. 679, 15-23 (2018)
- A.I. Kuzmenkov, et al., Sci Rep-UK. 6, 33314 (2016)
- L.M. Costantini, et al., Nature Commun. 6, 7670 (2015)